Since ZNF322A bound strongly to c-Myc, a transcription factor that reprograms mES, in our ChIP-seq dataset (Fig. 1b), we next validate if ZNF322A contributes to CSC-like formation and maintenance in lung cancer. This evidence concerns the gene ZNF322 and lung carcinoma.